Mantle-Cell Lymphoma

Authors: Jamés O. Armitage, Dan L. Longo - New England Journal of Medicine, NEJM 2022 cited by 138

Accounting for 5 to 7% of all lymphomas, mantle-cell lymphoma has historically been associated with a poor outcome, but survival is improving. The epidemiology, pathology, pathophysiology, diagnosis, and treatment of mantle-cell lymphoma are described.